U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07940647) titled 'A Safety and Tolerability Study of HJB647 in Adult Participants With Uncontrolled Hypertension' on Nov. 11.
Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of HJB647 at different doses in participants with uncontrolled hypertension (uHTN)
Study Start Date: Nov. 23
Study Type: INTERVENTIONAL
Condition:
Uncontrolled Hypertension
Intervention:
DRUG: HJB647
HJB647 oral capsules administered in adult participants with uncontrolled hypertension
DRUG: Placebo
Matching placebo capsules administered orally
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Novartis Pharmaceutical...